Quick Takeaways
- PAVmed Inc. filed SCHEDULE 13D/A for Lucid Diagnostics Inc. Common Stock, par value $0.001 per share (LUCD).
- Disclosed ownership: 28%.
- Date of event: 03 Feb 2026.
PAVmed Inc. - 03 Feb 2026 SCHEDULE 13D/A Report for Lucid Diagnostics Inc. Common Stock, par value $0.001 per share (LUCD)
- Filing Manager
- PAVmed Inc.
- Reporting Manager
- PAVmed Inc.
- Symbol
- LUCD
- Shares outstanding
- 141,152,375 shares
- Disclosed Ownership
- 38,816,903 shares
- Ownership
- 28%
- Form type
- SCHEDULE 13D/A
- Filing time
- 09 Feb 2026, 18:41:17 UTC
- Date of event
- 03 Feb 2026
- Previous filing
- 10 Oct 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"PAVmed Inc. disclosed 28% ownership in Lucid Diagnostics Inc. Common Stock, par value $0.001 per share (LUCD) on 03 Feb 2026."
What Changed
- Previous schedule filing date: 10 Oct 2025.
- Current filing was accepted on 09 Feb 2026, 18:41.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (1)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| PAVmed Inc. | 28% | 38,816,903 | 38,816,903 | /s/ Lishan Aklog, M.D. | Lishan Aklog, M.D. | 0001624326 |